Gamma delta T cells: a rising star in cancer therapy
Drug Target Review
FEBRUARY 28, 2024
from 2003 to 2006, covering the biotechnology and life-science tools sectors. Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. J Exp Med 198(5):747-755 (2003).
Let's personalize your content